Company Geovax Labs Inc OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Dodd
CEO | Chief Executive Officer | 74 | 10-03-16 |
Mark Reynolds
DFI | Director of Finance/CFO | 62 | 06-09-30 |
Erica Raiden
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-06 |
Kelly McKee
CTO | Chief Tech/Sci/R&D Officer | 74 | 22-01-05 |
Mark Newman
CTO | Chief Tech/Sci/R&D Officer | 69 | 09-12-31 |
Robert McNally
BRD | Director/Board Member | 76 | 06-11-30 |
John Sharkey
PRN | Corporate Officer/Principal | 67 | 22-06-12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert McNally
BRD | Director/Board Member | 76 | 06-11-30 |
Randal Chase
BRD | Director/Board Member | 74 | 15-03-18 |
John Spencer
BRD | Director/Board Member | 83 | 06-09-27 |
Dean Kollintzas
BRD | Director/Board Member | 51 | 06-09-27 |
David Dodd
CEO | Chief Executive Officer | 74 | 10-03-16 |
Nicole Lemerond
BRD | Director/Board Member | 49 | 22-08-30 |
Jayne Morgan
BRD | Director/Board Member | 61 | 22-12-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,308,309 | 2,271,620 ( 98.41 %) | 0 | 98.41 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+46.79% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- GOVX Stock
- Stock
- Company Geovax Labs Inc